期刊文献+

小鼠CDK4基因RNAi慢病毒载体的构建及体外研究

Construction and Identification of Lentivector-mediated CDK4-RNAi
下载PDF
导出
摘要 目的:探讨CDK4在神经系统变性疾病中的作用,并构建携带小鼠CDK4-siRNA的慢病毒载体进行体外研究。方法:设计3个CDK4-siRNA序列和1个无关对照序列,化学合成后退火形成双链,克隆到酶切的pSIH1-H1-copGFP siRNA载体。重组质粒经PCR和测序鉴定后,脂质体介导下转染BV-2细胞,Western blot检测CDK4的表达,筛选出干扰效果最佳的pSIH1-siRNA2。将对照序列和pSIH-siRNA2分别与慢病毒包装质粒共转染293T细胞生成病毒,收集病毒上清并浓缩,测定浓度。结果:慢病毒感染BV-2细胞后可表达GFP,RT-PCR和Western blot检测CDK4的表达明显下降。结论:成功构建携带CDK4-siRNA的慢病毒载体,体外研究显示其能明显下调CDK4的表达。 Objective: To study the role of CDK4 in pathogenesis of neurodegenerative disease. And to construct lentivector carrying murine CDK4-interference RNA (RNAi) for study in vitro. Methods:Three pairs of murine CDK4-siRNA and one pair of negative control sequence were designed, then cloned into pSIH1-HI-copGFP siRNA vector. The above recombinants were transfected into BV-2 cells mediated by lipofectamine. The gene silencing efficacy of 3 targets was compared by western-blot analysis. The optimized pSIHI-siRNA2 and pSIH-negative were co-transfected into 293T cells. The most effective (pSIH-siRNA2) was screened out by western blot. PSIH-nega- tive.pSIH-siRNA2 and lentiviral packaging plasmid were co-transfected into packging cell line 293T. Culture super- natants were harvested and condensed to generate the lentivirus encoding CDK4-RNAi. Results: GFP expression could be detected in BV-2 72 h after infection of the recombinant lentiviurs. And the expression of CDK4 decreased obviusly detected by RT-PCR and Western blotting. Conclusion: Lentivector carrying CDK4-siRNA is able to downregulate the expression of CDK4 gene in vitro signifcantly.
出处 《神经损伤与功能重建》 2008年第6期371-373,392,共4页 Neural Injury and Functional Reconstruction
基金 国家自然科学基金(No.3040014 No.30670737)
关键词 CDK4 神经系统变性疾病 RNA干扰 慢病毒载体 CDK4 neurodegenerative disease RNA interference lentiviral vector
  • 相关文献

参考文献1

二级参考文献20

  • 1Vanier MT et al. Brain Pathol, 1998, 8:163.
  • 2Elleder M et al. Acta Neuropathol (Berl), 1985, 66:325.
  • 3Loftus SK et al. Science, 1997, 277:232.
  • 4Bu Bet al. J Neurosci, 2002, 22:6515.
  • 5Zhang M et al. Am J Pathol, 2004, 165:843.
  • 6Bu B et al. Neurobiol Dis, 2002, 11:285.
  • 7Johnson DG. Oncogene, 1995, 11:1685.
  • 8Katayama K et al. Anticancer Res, 2003, 23:235.
  • 9Park DS et al. J Cell Biol, 1998, 143:457.
  • 10McShea A et al. Am J Pathol, 1997, 150:1933.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部